Free Trial
NASDAQ:BJDX

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis

Bluejay Diagnostics logo
$3.00 -0.34 (-10.03%)
As of 03:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Bluejay Diagnostics Stock (NASDAQ:BJDX)

Advanced

Key Stats

Today's Range
$2.99
$3.41
50-Day Range
$1.30
$3.50
52-Week Range
$1.26
$12.45
Volume
261,352 shs
Average Volume
1.94 million shs
Market Capitalization
$4.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Bluejay Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

BJDX MarketRank™: 

Bluejay Diagnostics scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bluejay Diagnostics is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bluejay Diagnostics is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Bluejay Diagnostics has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bluejay Diagnostics' valuation and earnings.
  • Percentage of Shares Shorted

    6.29% of the float of Bluejay Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bluejay Diagnostics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bluejay Diagnostics has recently decreased by 11.94%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bluejay Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Bluejay Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.29% of the float of Bluejay Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bluejay Diagnostics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bluejay Diagnostics has recently decreased by 11.94%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Bluejay Diagnostics has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Bluejay Diagnostics this week, compared to 0 articles on an average week.
  • Search Interest

    7 people have searched for BJDX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Bluejay Diagnostics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bluejay Diagnostics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.08% of the stock of Bluejay Diagnostics is held by insiders.

  • Percentage Held by Institutions

    Only 18.47% of the stock of Bluejay Diagnostics is held by institutions.

  • Read more about Bluejay Diagnostics' insider trading history.
Receive BJDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BJDX Stock News Headlines

Bluejay Diagnostics Raises $4M in Private Placement
Buy These 3 Stocks Before November 1
Quantum computing stocks like IONQ, D-Wave, and Rigetti have already surged as much as 4,000% — and with DARPA preparing a major announcement, I believe the next wave of gains could be even bigger. Join me this Tuesday, October 21, at 8 p.m. ET to discover my top three quantum stocks before the flashpoint hits.tc pixel
See More Headlines

BJDX Stock Analysis - Frequently Asked Questions

Bluejay Diagnostics' stock was trading at $4.87 at the start of the year. Since then, BJDX stock has decreased by 37.1% and is now trading at $3.0610.

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) released its quarterly earnings data on Thursday, August, 7th. The company reported ($1.41) earnings per share for the quarter.

Shares of Bluejay Diagnostics reverse split on Thursday, June 20th 2024.The 1-8 reverse split was announced on Thursday, June 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Bluejay Diagnostics (BJDX) raised $22 million in an IPO on Wednesday, November 10th 2021. The company issued 2,160,000 shares at $10.00 per share.

Shares of BJDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bluejay Diagnostics investors own include SoFi Technologies (SOFI), Athenex (ATNX), V.F. (VFC), Allarity Therapeutics (ALLR), Andersons (ANDE) and British American Tobacco (BTI).

Company Calendar

Last Earnings
8/07/2025
Today
10/16/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BJDX
CIK
1704287
Fax
N/A
Employees
9
Year Founded
2015

Profitability

EPS (Trailing Twelve Months)
($125.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.72 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-362.07%
Return on Assets
-299.10%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.56
Quick Ratio
4.56

Sales & Book Value

Annual Sales
$250 thousand
Price / Sales
19.91
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.34 per share
Price / Book
0.32

Miscellaneous

Outstanding Shares
1,490,000
Free Float
1,493,000
Market Cap
$4.98 million
Optionable
Not Optionable
Beta
0.54

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:BJDX) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners